These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35959282)

  • 1. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
    Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
    Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
    Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
    Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
    Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
    Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma
    Wang J; Li M; Jin L; Guo P; Zhang Z; Zhanghuang C; Tan X; Mi T; Liu J; Wu X; Wei G; He D
    Drug Deliv; 2022 Dec; 29(1):3291-3303. PubMed ID: 36352741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
    Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
    Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
    Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
    Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
    Chen W; Lin W; Yu N; Zhang L; Wu Z; Chen Y; Li Z; Gong F; Li N; Chen X; He X; Wu Y; Zeng X; Yueh Y; Xu R; Ji G
    Int J Nanomedicine; 2022; 17():5431-5446. PubMed ID: 36426375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
    Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
    J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet exosomes loaded with doxorubicin as a targeted therapy on triple-negative breast cancer cells.
    Uslu D; Abas BI; Demirbolat GM; Cevik O
    Mol Divers; 2024 Apr; 28(2):449-460. PubMed ID: 36576666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal transfer of MDR by exosomes in human osteosarcoma.
    Torreggiani E; Roncuzzi L; Perut F; Zini N; Baldini N
    Int J Oncol; 2016 Jul; 49(1):189-96. PubMed ID: 27176642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes miRNA-499a-5p targeted CD38 to alleviate anthraquinone induced cardiotoxicity: experimental research.
    Ma C; Yang Z; Wang J; She H; Tan L; Ye Q; Wang F; Feng X; Mo X; Liu K; Liu L
    Int J Surg; 2024 Apr; 110(4):1992-2006. PubMed ID: 38277348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
    Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-derived exosomes carrying microRNA-150 suppresses the proliferation and migration of osteosarcoma cells via targeting IGF2BP1.
    Xu Z; Zhou X; Wu J; Cui X; Wang M; Wang X; Gao Z
    Transl Cancer Res; 2020 Sep; 9(9):5323-5335. PubMed ID: 35117898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress.
    Yang Y; Chen Y; Zhang F; Zhao Q; Zhong H
    Int J Hyperthermia; 2015; 31(5):498-506. PubMed ID: 25955015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo.
    El-Derany MO; Noureldein MH
    Stem Cell Res Ther; 2021 Jun; 12(1):322. PubMed ID: 34090498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.